SuperworthOptimizeRx profit margin OPRX
Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.
- Net margin, 12 months
- 4.7%
- Operating margin, 12 months
- 11.1%
- Net margin on a year earlier
- +14.1 pts
- Peer median
- 4.1%
Over the twelve months to Jun 30, 2026, OptimizeRx kept 4.7% of its revenue as net profit, with an operating margin of 11.1% and a gross margin of 73.2%.
Five years earlier its net margin was 1.5%.
The median for 10 credit services stocks of a similar size is 4.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 4.7% | 10.7% | 67.3% |
| FY2024 | −21.8% | −14.9% | 64.5% |
| FY2023 | −24.6% | −36.9% | 60.0% |
| FY2022 | −18.3% | −19.7% | 62.4% |
| FY2021 | 0.6% | 0.6% | 58.1% |
| FY2020 | −5.1% | −4.9% | 55.7% |
| FY2019 | −12.8% | −15.0% | 62.8% |
| FY2018 | 1.1% | 0.8% | 57.6% |
| FY2017 | −17.3% | −17.6% | 49.1% |
| FY2016 | −19.9% | −20.4% | 56.0% |
| FY2015 | −8.2% | −8.3% | 49.8% |
| FY2014 | −15.8% | −15.8% | 50.5% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 4.7% | +14.1 pts | 11.1% | |
| Q1 FY26 | 6.4% | +22.7 pts | 13.2% | |
| Q4 FY25 | 4.7% | +26.5 pts | 10.7% | |
| Q3 FY25 | 0.0% | +27.4 pts | 6.2% | |
| Q2 FY25 | −9.4% | +12.1 pts | −3.6% | |
| Q1 FY25 | −16.3% | +6.8 pts | −11.4% | |
| Q4 FY24 | −21.8% | +2.7 pts | −14.9% | |
| Q3 FY24 | −27.4% | −5.5 pts | −32.0% | |
| Q2 FY24 | −21.5% | +1.8 pts | −27.9% | |
| Q1 FY24 | −23.1% | −0.3 pts | −31.1% | |
| Q4 FY23 | −24.6% | −6.2 pts | −36.9% | |
| Q3 FY23 | −21.9% | −5.3 pts | −26.0% |
Against its peers
Companies in Financial - Credit Services nearest OptimizeRx's size, closest first, today.
| Company | Profit margin |
|---|---|
| OPRXOptimizeRx | 4.7% |
| DHXDHI | 1.0% |
| CPSSConsumer Portfolio Services | 4.8% |
| SNFCASecurity National Financial | 11.1% |
| IMXIInternational Money Express | 3.4% |
| MACIMelar Acquisition Corp. I/Cayman | n/m |
| POWWOutdoor | 6.4% |
| IRHOIron Horse Acquisition II | n/m |
| RMRegional Management | 7.0% |
| LSAKLesaka Technologies | 0.4% |
| RMNIRimini Street | 1.7% |
| Peer median | 4.1% |
Where OptimizeRx ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on OptimizeRx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.